Literature DB >> 23065504

Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.

Achille Iolascon1, Maria Rosaria Esposito, Roberta Russo.   

Abstract

Congenital dyserythropoietic anemias belong to a group of inherited conditions characterized by a maturation arrest during erythropoiesis with a reduced reticulocyte production in contrast with erythroid hyperplasia in bone marrow. The latter shows specific morphological abnormalities that allowed for a morphological classification of these conditions mainly represented by congenital dyserythropoietic anemias types I and II. The identification of their causative genes provided evidence that these conditions have different molecular mechanisms that induce abnormal cell maturation and division. Some altered proteins seem to be involved in the chromatin assembly, such as codanin-1 in congenital dyserythropoietic anemia I. The gene involved in congenital dyserythropoietic anemia II, the most frequent form, is SEC23B. This condition seems to belong to a group of diseases attributable to defects in the transport of newly synthesized proteins from endoplasmic reticulum to the Golgi. This review will analyze recent insights in congenital dyserythropoietic anemias types I and II. It will also attempt to clarify the relationship between mutations in causative genes and the clinical phenotype of these conditions.

Entities:  

Mesh:

Year:  2012        PMID: 23065504      PMCID: PMC3590084          DOI: 10.3324/haematol.2012.072207

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  87 in total

Review 1.  Histone chaperones: an escort network regulating histone traffic.

Authors:  Leanne De Koning; Armelle Corpet; James E Haber; Geneviève Almouzni
Journal:  Nat Struct Mol Biol       Date:  2007-11-05       Impact factor: 15.369

2.  Replication stress interferes with histone recycling and predeposition marking of new histones.

Authors:  Zuzana Jasencakova; Annette N D Scharf; Katrine Ask; Armelle Corpet; Axel Imhof; Geneviève Almouzni; Anja Groth
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

3.  A Chinese family carrying novel mutations in SEC23B and HFE2, the genes responsible for congenital dyserythropoietic anaemia II (CDA II) and primary iron overload, respectively.

Authors:  Gang Liu; Shiwen Niu; Ailian Dong; Hao Cai; Gregory J Anderson; Bing Han; Guangjun Nie
Journal:  Br J Haematol       Date:  2012-03-20       Impact factor: 6.998

4.  CDAII presenting as hydrops foetalis: molecular characterization of two cases.

Authors:  Elisa Fermo; Paola Bianchi; Lucia Dora Notarangelo; Silvana Binda; Cristina Vercellati; Anna Paola Marcello; Carla Boschetti; Wilma Barcellini; Alberto Zanella
Journal:  Blood Cells Mol Dis       Date:  2010-04-09       Impact factor: 3.039

5.  The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability.

Authors:  Roy Drissen; Marieke von Lindern; Andrea Kolbus; Siska Driegen; Peter Steinlein; Hartmut Beug; Frank Grosveld; Sjaak Philipsen
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

6.  Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to-Golgi trafficking.

Authors:  Simeon A Boyadjiev; J Christopher Fromme; Jin Ben; Samuel S Chong; Christopher Nauta; David J Hur; George Zhang; Susan Hamamoto; Randy Schekman; Mariella Ravazzola; Lelio Orci; Wafaa Eyaid
Journal:  Nat Genet       Date:  2006-09-17       Impact factor: 38.330

7.  Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.

Authors:  Guillem Casanovas; Dorine W Swinkels; Sandro Altamura; Klaus Schwarz; Coby M Laarakkers; Hans-Juergen Gross; Markus Wiesneth; Hermann Heimpel; Martina U Muckenthaler
Journal:  J Mol Med (Berl)       Date:  2011-04-08       Impact factor: 4.599

8.  Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.

Authors:  Giovanni Carlo Del Vecchio; Lucia Giordani; Attilio De Santis; Domenico De Mattia
Journal:  Acta Haematol       Date:  2005       Impact factor: 2.195

9.  SEC23B is required for the maintenance of murine professional secretory tissues.

Authors:  Jiayi Tao; Min Zhu; He Wang; Solomon Afelik; Matthew P Vasievich; Xiao-Wei Chen; Guojing Zhu; Jan Jensen; David Ginsburg; Bin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-28       Impact factor: 11.205

10.  Geographic distribution of CDA-II: did a founder effect operate in Southern Italy?

Authors:  A Iolascon; V Servedio; R Carbone; A Totaro; M Carella; S Perrotta; S N Wickramasinghe; J Delaunay; H Heimpel; P Gasparini
Journal:  Haematologica       Date:  2000-05       Impact factor: 9.941

View more
  26 in total

Review 1.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

2.  Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development.

Authors:  Antanas Planutis; Li Xue; Cecelia D Trainor; Mohan Dangeti; Kevin Gillinder; Miroslawa Siatecka; Danitza Nebor; Luanne L Peters; Andrew C Perkins; James J Bieker
Journal:  Development       Date:  2017-02-01       Impact factor: 6.868

3.  New Codanin-1 Gene Mutations in a Italian Patient with Congenital Dyserythropoietic Anemia Type I and Heterozygous Beta-Thalassemia.

Authors:  Elena D'Alcamo; V Agrigento; L Pitrolo; S Sclafani; R Barone; G Calvaruso; V Buffa; A Maggio
Journal:  Indian J Hematol Blood Transfus       Date:  2016-01-05       Impact factor: 0.900

4.  Compound heterozygosity for KLF1 mutations is associated with microcytic hypochromic anemia and increased fetal hemoglobin.

Authors:  Jiwei Huang; Xinhua Zhang; Dun Liu; Xiaofeng Wei; Xuan Shang; Fu Xiong; Lihua Yu; Xiaolin Yin; Xiangmin Xu
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

Review 5.  Trafficking mechanisms of extracellular matrix macromolecules: insights from vertebrate development and human diseases.

Authors:  Gokhan Unlu; Daniel S Levic; David B Melville; Ela W Knapik
Journal:  Int J Biochem Cell Biol       Date:  2013-12-09       Impact factor: 5.085

Review 6.  The inherited bone marrow failure syndromes.

Authors:  S Deborah Chirnomas; Gary M Kupfer
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

7.  Congenital dyserythropoietic anemia type 1 with a novel mutation in the CDAN1 gene previously diagnosed as congenital hemolytic anemia.

Authors:  Hisanori Fujino; Sayoko Doisaki; Young-Dong Park; Asahito Hama; Hideki Muramatsu; Seiji Kojima; Shinichi Sumimoto
Journal:  Int J Hematol       Date:  2013-04-19       Impact factor: 2.490

8.  Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis.

Authors:  Timothy J Satchwell; Stephanie Pellegrin; Paola Bianchi; Bethan R Hawley; Alexandra Gampel; Kathryn E Mordue; Annika Budnik; Elisa Fermo; Wilma Barcellini; David J Stephens; Emile van den Akker; Ashley M Toye
Journal:  Haematologica       Date:  2013-08-09       Impact factor: 9.941

9.  Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia.

Authors:  Motoharu Hamada; Sayoko Doisaki; Yusuke Okuno; Hideki Muramatsu; Asahito Hama; Nozomu Kawashima; Atsushi Narita; Nobuhiro Nishio; Kenichi Yoshida; Hitoshi Kanno; Atsushi Manabe; Takashi Taga; Yoshiyuki Takahashi; Satoru Miyano; Seishi Ogawa; Seiji Kojima
Journal:  Int J Hematol       Date:  2018-06-23       Impact factor: 2.490

Review 10.  Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.

Authors:  Achille Iolascon; Hermann Heimpel; Anders Wahlin; Hannah Tamary
Journal:  Blood       Date:  2013-08-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.